Key facts
- This page summarizes Richard Brudnick's Form 4 filing for VOLITIONRX LTD (VNRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Jan 2023, 15:03.
Richard Brudnick - 12 Jan 2023 Form 4 Insider Report for VOLITIONRX LTD (VNRX)
- Reporting relationship
- Director
- Issuer ticker
- VNRX
- Reported as of
- 12 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 13 Jan 2023, 15:03:54 UTC
- Prior SEC filing
- 19 Oct 2022
- Next SEC filing
- 04 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Richard Brudnick
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Richard Brudnick filed Form 4 for VOLITIONRX LTD (VNRX) on 13 Jan 2023.
Change
- Previous filing in this sequence was filed on 19 Oct 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VNRX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +5,625
- Change %
- +25%
- Price
- $0.000000
- Shares after
- 27,936
- Date
- 12 Jan 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
On October 4, 2022, the reporting person was awarded 15,000 restricted stock units under the Issuer's 2015 Stock Incentive Plan, subject to vesting upon the achievement of certain corporate performance goals on or prior to December 31, 2022 and June 30, 2023 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 5,625 restricted stock units vesting. The restricted stock units are further subject to a 3-year time-based vesting schedule, vesting in three equal installments of 1,875 units on each of October 4, 2023, October 4, 2024 and October 4, 2025, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. As reported in October 2022, the rights with respect to 2,625 restricted stock units subject to the award previously vested and remain subject to time-based vesting.